Study of Novel Treatment Combination Therapies in Participants With Head and Neck Squamous Cell Carcinoma Regardless of PD-L1 Expression Status; Subst
A phase 2 trial of Domvanalimab, Zimberelimab, Paclitaxel / nab-paclitaxel in head and neck squamous cell carcinoma, run by Gilead Sciences, active and no longer recruiting.
Overview
Study of Novel Treatment Combination Therapies in Participants With Head and Neck Squamous Cell Carcinoma Regardless of PD-L1 Expression Status; Substudy-01 is a phase 2 interventional study registered as NCT06727565 by Gilead Sciences, with 39 participants enrolled, started 2025-02-18 and due to reach its primary completion in 2027-03. Interventions recorded: Domvanalimab, Zimberelimab, Paclitaxel, Carboplatin. Conditions listed: Head and Neck Squamous Cell Carcinoma. No results are recorded here; the registry entry is the source.
Similar pages
not linked directly; found by shared links- TrialStudy of Novel Treatment Combinations in Patients With Lung Cancer
Shares Domvanalimab, Zimberelimab, Gilead Sciences (incl. Kite), Carboplatin.
- TrialStudy Evaluating Effectiveness and Safety of Zimberelimab and Domvanalimab in Lung Cancer
Shares Domvanalimab, Zimberelimab, Paclitaxel / nab-paclitaxel, Carboplatin.
- TrialStudy With Various Immunotherapy Treatments in Participants With Lung Cancer
Shares Domvanalimab, Zimberelimab, Gilead Sciences (incl. Kite).
- TrialZimberelimab and Domvanalimab in Combination With Chemotherapy Versus Pembrolizumab With Chemotherapy in Patients With Untreated Metastatic Non-Small Cell Lung Cancer
Shares Domvanalimab, Gilead Sciences (incl. Kite).
- TrialA Safety and Efficacy Study of Treatment Combinations With and Without Chemotherapy in Adult Participants With Advanced Upper Gastrointestinal Tract Malignancies
Shares Domvanalimab, Zimberelimab, Gilead Sciences (incl. Kite).
- TrialStudy of Sacituzumab Govitecan in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread
Shares Zimberelimab, Gilead Sciences (incl. Kite), Carboplatin.
- TrialStudy of TL117 in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Shares Paclitaxel / nab-paclitaxel, Head and neck squamous cell carcinoma.
- TrialCATALINA-4: A Study to Investigate the Safety and Efficacy of TORL-1-23 With Chemotherapy Given Before Initial Surgery in Women With Advanced Stage Ov
Shares Paclitaxel / nab-paclitaxel, Carboplatin.